SpaceOAR Vue™ Hydrogel
Radiopaque Perirectal Spacer for Radiation Therapy
SpaceOAR Vue Hydrogel is a new generation hydrogel spacer that offers enhanced visibility via CT scan, designed to help physicians improve contouring accuracy and consistently position patients receiving prostate cancer radiation, as compared to SpaceOAR™ Hydrogel.1
SpaceOAR Vue Hydrogel in different image modalities.
Optimize dosing plan
Visibility of the gel on a CT scan designed to help to reduce under- or over-contouring of the prostate and rectum for improved accuracy, as compared to SpaceOAR Hydrogel, and helps optimize treatment planning.1,2
Treatment planning can be done using CT only, reducing the need to acquire, reference and fuse MR and CT images to aid in visualization of the target region enabling appropriate patient positioning for radiation treatment using kV cone-beam CT.1
Treat more patients
The radiopacity may provide a suitable imaging option to MRI for patients with implanted metallic devices.1
Interested in learning more about SpaceOAR Vue Hydrogel?
*Jeff Michalski, MD (2020). Permission granted by Washington University Imaging.
1. Data on file with Boston Scientific.
2. Xu H, Gordon JJ, Siebers JV. Coverage-based treatment planning to accommodate delineation uncertainties in prostate cancer treatment. Med Phys.2015 Sep;42(9):5435-43.
SpaceOAR Vue Hydrogel is intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer and in creating this space it is the intent of SpaceOAR Vue Hydrogel to reduce the radiation dose delivered to the anterior rectum. SpaceOAR Vue Hydrogel contains polyethylene glycol (PEG) and iodine. Prior to using these devices, please review the Instructions for Use for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. As with any medical treatment, there are some risks involved with the use of SpaceOAR Vue Hydrogel. Potential complications associated with SpaceOAR Vue Hydrogel include, but are not limited to: pain associated with SpaceOAR Vue Hydrogel injection, pain or discomfort associated with SpaceOAR Vue Hydrogel, local inflammatory reactions, infection (including abscess), urinary retention, urgency, constipation (acute, chronic, or secondary to outlet perforation), rectal tenesmus/muscle spasm, mucosal damage, ulcers, fistula, perforation (including prostate, bladder, urethra, rectum), necrosis, allergic reaction (localized or more severe reaction, such as anaphylaxis), embolism (venous or arterial embolism is possible and may present outside of the pelvis, potentially impacting vital organs or extremities), syncope and bleeding. The occurrence of one or more of these complications may require treatment or surgical intervention. URO-989810-AB MAR 2022
CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings and instructions for use can be found in the product labeling supplied with each device. Information for use only in countries with applicable health authority registrations. This material not intended for use in France.
Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. Please check availability with your local sales representative or customer service.
SpaceOAR and SpaceOAR Vue Hydrogels are intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer and in creating this space it is the intent of SpaceOAR and SpaceOAR Vue Hydrogels to reduce the radiation dose delivered to the anterior rectum.
As with any medical treatment, there are some risks involved with the use of SpaceOAR and SpaceOAR Vue Hydrogels. Potential complications associated with SpaceOAR and SpaceOAR Vue Hydrogels include, but are not limited to: pain associated with SpaceOAR and SpaceOAR Vue Hydrogels injection; pain or discomfort associated with SpaceOAR and SpaceOAR Vue Hydrogels; needle penetration of the bladder, prostate, rectal wall, rectum or urethra; injection of SpaceOAR and SpaceOAR Vue Hydrogels into the bladder, prostate, rectal wall, rectum or urethra; local inflammatory reactions; infection; injection of air, fluid or SpaceOAR and SpaceOAR Vue Hydrogels intravascularly; urinary retention; rectal mucosal damage, ulcers, necrosis; bleeding; and rectal urgency.
All images are the property of Boston Scientific. All trademarks are the property of their respective owners.